IQV
IQVIA Holdings Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$266.63
−1.84%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
19.6x
EV/EBITDA
16.5x
Market Cap
$43.89B
MomentumView details →
1D Return
−1.84%
YTD Return
+18.90%
RSI (14)
73.3
ValuationView details →
P/E (Fwd)
19.6x
EV/EBITDA
16.5x
Market Cap
$43.89B
RSI (14)
73.3
MomentumView details →
1D Return
−1.84%
YTD Return
+18.90%
SummaryUpdated Jun 1, 2026
IQVIA Holdings Inc. (NASDAQ:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Founded in 1982 and originally known as Quintiles IMS Holdings, the company changed its name to IQVIA in November 2017. Headquartered in Durham, North Carolina, IQVIA was formed through the merger of Quintiles (a clinical research organization) and IMS Health (a healthcare data and analytics company). Today, the company operates across the Americas, Europe, Africa, and the Asia-Pacific region, serving pharmaceutical, biotechnology, device and diagnostic, and consumer health companies worldwide.
Similar companies
Latest newsMore news →
Iqvia Holdings Inc. stock reached a 52-week high of $260.32, reflecting a 38% gain over the past year and a 54.6% surge over the past six months.14d agoBlackRock Inc. acquired a new position in IQVIA Holdings Inc., buying 14,549,693 shares valued at approximately $2.81 billion, representing about 8.84% ownership, as disclosed in a 13F filing.15d ago